• Affiliate Professor, Global Health

325 Ninth Avenue
Box 359909
Seattle, WA 98104
United States

Phone Number: 
206-543-4278
Fax: 
Email: 
mhchung@uw.edu
Select from the following:
Biography 

Dr. Michael Chung has been based overseas for nearly 20 years implementing global health programs in Africa and Southeast Asia. In the Department of Global Health at the University of Washington, he is an Affiliate Professor leading the Treatment, Research, and Expert Education (TREE) program. He spent a number of years living in Nairobi, Kenya where he co-founded the Coptic Hope Center for Infectious Diseases and worked at the University of Nairobi and Kenyatta National Hospital, as well as Hanoi, Vietnam where he taught at Bach Mai Hospital and Hanoi Medical University. Dr. Chung has led many randomized clinical trials in resource-limited settings and his current research is focused on examining cervical cancer screening and treatment among HIV-positive women, HIV chronic pulmonary disease, and cardiovascular disease associated with COVID-19 infection. He served as Chair of the Department of Medicine at Aga Khan University East Africa where he currently leads an NIH Fogarty D43 HPV research training grant and G11 program to build capacity among research administrators. Most recently, Dr. Chung joined the faculty in the Department of Medicine at Emory University in Atlanta, USA.

Education 
  • MD (University of Chicago)
  • MPH (Harvard University)
  • BA (Oberlin College)
Country Affiliations 
Health Topics 
  • Cardiovascular Disease
  • Cervical Cancer
  • Clinical Mentoring
  • Cost-Effectiveness
  • COVID-19
  • Distance Learning
  • Education and Training
  • HIV/AIDS
  • Pulmonary Diseases and Pneumonia
DGH Centers, Programs and Initiatives and Affiliated Organizations 
Publications 

Greene SA, De Vuyst H, John-Stewart GC, McGrath CJ, Marson KG, Trinh TT, Yatich N, Kiptinness C, Cagle A, Nyongesa Malava E, Sakr SR, Mugo NR, Chung MH. Effectiveness of Cryotherapy versus Loop Electrosurgical Excision Procedure Among HIV-Infected Women: A Randomized Controlled Trial. 2019. JAMA. Oct 22;322(16):1570-1579. doi: 10.1001/jama.2019.14969

Chung MH, McGrath CJ, Levine M, Milne RS, Kiarie JN, So I, Andersen N, Dross S, Coombs RW, Chohan B, Yatich N, Kitpinness C, Sakr SR, Beck IA, Frenkel LM. Randomized Clinical Trial Detecting Pre-Treatment HIV Drug Resistance by Oligonucleotide Ligation Assay in Kenya. 2019. Lancet HIV. doi: 10.1016/S2352-3018(19)30337-6

Silverman RA, Beck IA, Kiptinness C, Levine M, McGrath CJ, Bii S, Richardson BA, John-Stewart GC, Chohan B, Sakr SR, Kiarie JN, Frenkel LM, Chung MH. Prevalence of Pre-antiretroviral Treatment Drug Resistance by Gender, Age, and Other Factors in HIV-infected Individuals Initiating Therapy in Kenya, 2013-2014. 2017. Journal of Infectious Diseases. Dec 19; 216(12):1569-1578. doi: 10.1093/infdis/jix544

Greene SA, McGrath CJ, Lehman DA, Marson KG, Trinh R, Yatich N, Nyongesa-Malava E, Kiptinness C, Richardson BA, John-Stewart GC, De Vuyst D, Sakr SR, Mugo NR, Chung MH. Increased Cervical HIV RNA Shedding Among HIV-Infected Women Randomized to Loop Electrosurgical Excision Procedure (LEEP) compared to Cryotherapy for Cervical Intraepithelial Neoplasia 2/3. 2017. Clinical Infectious Diseases. May 17;66(11):1778-1784. doi: 10.1093/cid/cix1096